Insider Trading: Achillion Pharmaceuticals Inc (ACHN.O)

ACHN.O on Nasdaq

7.77USD
17 May 2013
Price Change (% chg)

$0.21 (+2.78%)
Prev Close
$7.56
Open
$7.60
Day's High
$7.82
Day's Low
$7.56
Volume
823,358
Avg. Vol
1,126,389
52-wk High
$11.36
52-wk Low
$5.42

Search Stocks
SHAH GAUTAM Options Exercised: 0
Trade Date: Wednesday, 26 Sep 2012 Price: 4.82
Title: Officer Shares Held: 3,125
Type Traded: Direct Net Change in Shares This Filing: 0

Institutional Holders

% Shares Owned: 0.00%
# of Holders: 168
Total Shares Held: 99,780,224
3 Mo. Net Change: 16,633,874
# New Positions: 28
# Closed Positions: 16
# Increased Positions: 101
# Reduced Positions: 52
# Net Buyers: 49

Officers & Directors

Name Age Since Current Position

David Scheer

60 2010 Chairman of the Board

Michael Kishbauch

63 2004 President, Chief Executive Officer, Director

Mary Fenton

48 2010 Chief Financial Officer, Senior Vice President

Gautam Shah

56 2012 Executive Vice President, Chief Compliance Officer

Joseph Truitt

48 2012 Senior Vice President, Chief Commercial Officer

Milind Deshpande

55 2010 President - Research and Development, Chief Scientific Officer

Jason Fisherman

54 2000 Independent Director

Gary Frashier

74 2008 Independent Director

Kurt Graves

44 2012 Independent Director

Dennis Liotta

2008 Independent Director

Robert Van Nostrand

55 2007 Independent Director

Nicole Vitullo

47 2010 Independent Director

David Wright

63 2007 Independent Director
Search Stocks